GIC

SEC source: 0001628280-19-007621 · wf-form4_155977023433533.xml · nonDerivative · entry 1

LINDBLOOM CHAD · CIK 0001241107 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,778

F1 · security: On June 3, 2019 (the date of the Issuer's 2019 annual meeting of stockholders), the reporting person was granted 1,839 restricted stock units pursuant to the Issuer's 2010 Long Term Incentive Plan. Such units vest on June 3, 2021 (the "Vesting Date"); provided that the reporting person continues to be a director of the Issuer through and on the Vesting Date.

F2 · shares: The number of restricted stock units was determined by dividing $40,000 by the closing price per share during the 20 trading days preceding the date of the Issuer's 2019 annual meeting of stockholders (rounded up to the nearest whole number of shares).

SEC source: 0001243729-19-000006 · wf-form4_155976703811984.xml · nonDerivative · entry 1

ROSENTHAL ROBERT · CIK 0001243729 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,499

F1 · security: On June 3, 2019 (the date of the Issuer's 2019 annual meeting of stockholders), the reporting person was granted 1,839 restricted stock units pursuant to the Issuer's 2010 Long Term Incentive Plan. Such units vest on June 3, 2021 (the "Vesting Date"); provided that the reporting person continues to be a director of the Issuer through and on the Vesting Date.

F2 · shares: The number of restricted stock units was determined by dividing $40,000 by the closing price per share during the 20 trading days preceding the date of the Issuer's 2019 annual meeting of stockholders (rounded up to the nearest whole number of shares).

SEC source: 0001216763-19-000011 · wf-form4_155982567488361.xml · nonDerivative · entry 1

REINHOLD LAWRENCE P · CIK 0001216763 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 181,850

F1 · security: On June 3, 2019 (the date of the Issuer's 2019 annual meeting of stockholders), the reporting person was granted 1,839 restricted stock units pursuant to the Issuer's 2010 Long Term Incentive Plan. Such units vest on June 3, 2021 (the "Vesting Date"); provided that the reporting person continues to be a director of the Issuer through and on the Vesting Date.

F2 · shares: The number of restricted stock units was determined by dividing $40,000 by the closing price per share during the 20 trading days preceding the date of the Issuer's 2019 annual meeting of stockholders (rounded up to the nearest whole number of shares).

SEC source: 0001216763-19-000008 · wf-form4_155777868485321.xml · derivative · entry 3

REINHOLD LAWRENCE P · CIK 0001216763 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 50,000 shares

Expires 2019-05-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Cashless exercise of 50,000 options and immediate sale of 35,000 shares of common stock through broker of an award granted on May 18, 2009.

F3 · derivative.exercise_date: The options granted on May 18, 2009 had a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001216763-19-000008 · wf-form4_155777868485321.xml · nonDerivative · entry 2

REINHOLD LAWRENCE P · CIK 0001216763 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,011

F1 · kind: Cashless exercise of 50,000 options and immediate sale of 35,000 shares of common stock through broker of an award granted on May 18, 2009.

F2 · price: This transaction was executed in multiple trades at prices ranging from $22.00 to $22.51. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001216763-19-000008 · wf-form4_155777868485321.xml · nonDerivative · entry 1

REINHOLD LAWRENCE P · CIK 0001216763 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 215,011

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Cashless exercise of 50,000 options and immediate sale of 35,000 shares of common stock through broker of an award granted on May 18, 2009.

SEC source: 0001738394-19-000010 · wf-form4_155613913916408.xml · derivative · entry 1

Chaturbedi Ritesh · CIK 0001738394 · SVP & Chief Operations Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,880

Underlying: Common Stock · 25,880 shares

Expires 2029-04-22

F1 · derivative.exercise_date: The Employee Stock Option (right to buy) granted on April 22, 2019 had a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001764073-19-000007 · wf-form4_155190775192198.xml · nonDerivative · entry 1

Fielding Donna · CIK 0001764073 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 377

F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Systemax Inc. Employee Stock Purchase Plan ("ESPP") on March 4, 2019. This transaction is exempt under Rule 16b-3(c).

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on March 1, 2019.

SEC source: 0001615469-19-000004 · wf-form4_155191016050704.xml · nonDerivative · entry 1

Shetty Manoj · CIK 0001615469 · Senior VP & Chief Info Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 583

F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Systemax Inc. Employee Stock Purchase Plan ("ESPP") on March 4, 2019. This transaction is exempt under Rule 16b-3(c).

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on March 1, 2019.

SEC source: 0001689126-19-000007 · wf-form4_155190794216586.xml · nonDerivative · entry 1

Clark Thomas Eugene · CIK 0001689126 · Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,130

F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Systemax Inc. Employee Stock Purchase Plan ("ESPP") on March 4, 2019. This transaction is exempt under Rule 16b-3(c).

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on March 1, 2019.

SEC source: 0001140170-19-000004 · wf-form4_155190763314608.xml · nonDerivative · entry 1

AXMACHER THOMAS · CIK 0001140170 · VP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 272

F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Systemax Inc. Employee Stock Purchase Plan ("ESPP") on March 4, 2019. This transaction is exempt under Rule 16b-3(c).

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on March 1, 2019.

SEC source: 0001243716-19-000005 · wf-form4_155208003613315.xml · nonDerivative · entry 2

DOOLEY ROBERT · CIK 0001243716 · President, Industrial Prod GRP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,264

F3 · security: The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Systemax Inc. Employee Stock Purchase Plan ("ESPP") on March 4, 2019. This transaction is exempt under Rule 16b-3(c).

F4 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on March 1, 2019.

F2 · balance_after: The amount of non-derivative securities beneficially owned as of the date of the filing of this Form 5 is 85,264, which includes 15,000 unvested Restricted Stock Units that were granted on March 1, 2012 and 70,264 shares of common stock.

SEC source: 0001243716-19-000005 · wf-form4_155208003613315.xml · nonDerivative · entry 1

DOOLEY ROBERT · CIK 0001243716 · President, Industrial Prod GRP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,264

F1 · security: Represents the number of shares sold to cover tax withholding in connection with the vesting of restricted stock units.

F2 · balance_after: The amount of non-derivative securities beneficially owned as of the date of the filing of this Form 5 is 85,264, which includes 15,000 unvested Restricted Stock Units that were granted on March 1, 2012 and 70,264 shares of common stock.

SEC source: 0001549062-19-000007 · wf-form4_155026876667520.xml · nonDerivative · entry 1

Lerner Eric · CIK 0001549062 · Senior VP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,321

F1 · shares: Shares surrendered for payment of tax liability incident to vesting of prior restricted stock award.

SEC source: 0001689126-19-000005 · wf-form4_155026829099000.xml · nonDerivative · entry 1

Clark Thomas Eugene · CIK 0001689126 · Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,614

F1 · shares: Shares surrendered for payment of tax liability incident to vesting of prior restricted stock award.

SEC source: 0001243729-19-000002 · wf-form4_154819372901180.xml · derivative · entry 2

ROSENTHAL ROBERT · CIK 0001243729 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2026-10-31

F1 · kind: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") that became effective on January 17, 2019 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option (right to buy) has been amended to reduce such exercise price by $2.30. There have been no other changes to the terms of the Stock Option (right to buy). The Option Repricing was related to a special dividend declared in December 2018.

F2 · derivative.exercise_date: The Stock Option (right to buy) granted on October 31, 2016 vested in three installments: 3,334 shares on October 31, 2017; 3,333 shares on October 31, 2018 and 3,333 shares October 31, 2019.

SEC source: 0001243729-19-000002 · wf-form4_154819372901180.xml · derivative · entry 1

ROSENTHAL ROBERT · CIK 0001243729 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2026-10-31

F1 · kind: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") that became effective on January 17, 2019 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option (right to buy) has been amended to reduce such exercise price by $2.30. There have been no other changes to the terms of the Stock Option (right to buy). The Option Repricing was related to a special dividend declared in December 2018.

F2 · derivative.exercise_date: The Stock Option (right to buy) granted on October 31, 2016 vested in three installments: 3,334 shares on October 31, 2017; 3,333 shares on October 31, 2018 and 3,333 shares October 31, 2019.

SEC source: 0001216763-19-000006 · wf-form4_154819108378086.xml · derivative · entry 8

REINHOLD LAWRENCE P · CIK 0001216763 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2026-12-14

F1 · kind: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") that became effective on January 17, 2019 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Employee Stock Option (right to buy) has been amended to reduce such exercise price by $2.30. There have been no other changes to the terms of the Employee Stock Option (right to buy). The Option Repricing was related to a special dividend declared in December 2018.

F5 · derivative.exercise_date: The options granted on December 14, 2016 had a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001216763-19-000006 · wf-form4_154819108378086.xml · derivative · entry 7

REINHOLD LAWRENCE P · CIK 0001216763 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 100,000 shares

Expires 2026-12-14

F1 · kind: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") that became effective on January 17, 2019 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Employee Stock Option (right to buy) has been amended to reduce such exercise price by $2.30. There have been no other changes to the terms of the Employee Stock Option (right to buy). The Option Repricing was related to a special dividend declared in December 2018.

F5 · derivative.exercise_date: The options granted on December 14, 2016 had a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001216763-19-000006 · wf-form4_154819108378086.xml · derivative · entry 6

REINHOLD LAWRENCE P · CIK 0001216763 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2026-02-01

F1 · kind: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") that became effective on January 17, 2019 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Employee Stock Option (right to buy) has been amended to reduce such exercise price by $2.30. There have been no other changes to the terms of the Employee Stock Option (right to buy). The Option Repricing was related to a special dividend declared in December 2018.

F4 · derivative.exercise_date: The options granted on February 1, 2016 had a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001216763-19-000006 · wf-form4_154819108378086.xml · derivative · entry 5

REINHOLD LAWRENCE P · CIK 0001216763 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2026-02-01

F1 · kind: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") that became effective on January 17, 2019 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Employee Stock Option (right to buy) has been amended to reduce such exercise price by $2.30. There have been no other changes to the terms of the Employee Stock Option (right to buy). The Option Repricing was related to a special dividend declared in December 2018.

F4 · derivative.exercise_date: The options granted on February 1, 2016 had a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001216763-19-000006 · wf-form4_154819108378086.xml · derivative · entry 4

REINHOLD LAWRENCE P · CIK 0001216763 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2021-11-14

F1 · kind: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") that became effective on January 17, 2019 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Employee Stock Option (right to buy) has been amended to reduce such exercise price by $2.30. There have been no other changes to the terms of the Employee Stock Option (right to buy). The Option Repricing was related to a special dividend declared in December 2018.

F3 · derivative.exercise_date: The options granted on November 14, 2011 had a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001216763-19-000006 · wf-form4_154819108378086.xml · derivative · entry 3

REINHOLD LAWRENCE P · CIK 0001216763 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 50,000 shares

Expires 2021-11-14

F1 · kind: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") that became effective on January 17, 2019 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Employee Stock Option (right to buy) has been amended to reduce such exercise price by $2.30. There have been no other changes to the terms of the Employee Stock Option (right to buy). The Option Repricing was related to a special dividend declared in December 2018.

F3 · derivative.exercise_date: The options granted on November 14, 2011 had a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001216763-19-000006 · wf-form4_154819108378086.xml · derivative · entry 2

REINHOLD LAWRENCE P · CIK 0001216763 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2019-05-18

F1 · kind: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") that became effective on January 17, 2019 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Employee Stock Option (right to buy) has been amended to reduce such exercise price by $2.30. There have been no other changes to the terms of the Employee Stock Option (right to buy). The Option Repricing was related to a special dividend declared in December 2018.

F2 · derivative.exercise_date: The options granted on May 18, 2009 had a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001216763-19-000006 · wf-form4_154819108378086.xml · derivative · entry 1

REINHOLD LAWRENCE P · CIK 0001216763 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 50,000 shares

Expires 2019-05-18

F1 · kind: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") that became effective on January 17, 2019 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Employee Stock Option (right to buy) has been amended to reduce such exercise price by $2.30. There have been no other changes to the terms of the Employee Stock Option (right to buy). The Option Repricing was related to a special dividend declared in December 2018.

F2 · derivative.exercise_date: The options granted on May 18, 2009 had a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001718653-19-000001 · wf-form4_154819144339068.xml · derivative · entry 2

Kipe David · CIK 0001718653 · SVP & Chief Operations Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,550

Underlying: Common Stock · 17,550 shares

Expires 2028-10-02

F1 · kind: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") that became effective on January 17, 2019 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Employee Stock Option (right to buy) has been amended to reduce such exercise price by $2.30. There have been no other changes to the terms of the Employee Stock Option (right to buy). The Option Repricing was related to a special dividend declared in December 2018.

F2 · derivative.exercise_date: On October 2, 2018, the reporting person was granted 17,550 stock options pursuant to the Company's 2010 Long Term Incentive Plan, which vest over three years in equal installments of 5,850, starting on February 1, 2020 based on the achievement of a minimum adjusted operating income as determined in a manner consistent with the methods used in the Issuer's regular reports on Form 10K and Form 10Q.

SEC source: 0001718653-19-000001 · wf-form4_154819144339068.xml · derivative · entry 1

Kipe David · CIK 0001718653 · SVP & Chief Operations Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 17,550 shares

Expires 2028-10-02

F1 · kind: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") that became effective on January 17, 2019 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Employee Stock Option (right to buy) has been amended to reduce such exercise price by $2.30. There have been no other changes to the terms of the Employee Stock Option (right to buy). The Option Repricing was related to a special dividend declared in December 2018.

F2 · derivative.exercise_date: On October 2, 2018, the reporting person was granted 17,550 stock options pursuant to the Company's 2010 Long Term Incentive Plan, which vest over three years in equal installments of 5,850, starting on February 1, 2020 based on the achievement of a minimum adjusted operating income as determined in a manner consistent with the methods used in the Issuer's regular reports on Form 10K and Form 10Q.

SEC source: 0001764073-19-000005 · wf-form4_154819082190578.xml · derivative · entry 1

Fielding Donna · CIK 0001764073 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,253

Underlying: Common Stock · 15,253 shares

Expires 2029-01-17

F1 · derivative.exercise_date: The Employee Stock Option (right to buy) granted on January 17, 2019 had a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001689126-19-000001 · wf-form4_154816489841616.xml · derivative · entry 5

Clark Thomas Eugene · CIK 0001689126 · Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,948

Underlying: Common Stock · 24,948 shares

Expires 2029-01-17

F4 · derivative.exercise_date: The Employee Stock Option (right to buy) granted on January 17, 2019 had a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001689126-19-000001 · wf-form4_154816489841616.xml · derivative · entry 4

Clark Thomas Eugene · CIK 0001689126 · Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2026-11-10

F1 · kind: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") that became effective on January 17, 2019 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Employee Stock Option (right to buy) has been amended to reduce such exercise price by $2.30. There have been no other changes to the terms of the Employee Stock Option (right to buy). The Option Repricing was related to a special dividend declared in December 2018.

F3 · derivative.exercise_date: The Employee Stock Option (right to buy) granted on November 10, 2016 had a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001689126-19-000001 · wf-form4_154816489841616.xml · derivative · entry 3

Clark Thomas Eugene · CIK 0001689126 · Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 35,000 shares

Expires 2026-11-10

F1 · kind: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") that became effective on January 17, 2019 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Employee Stock Option (right to buy) has been amended to reduce such exercise price by $2.30. There have been no other changes to the terms of the Employee Stock Option (right to buy). The Option Repricing was related to a special dividend declared in December 2018.

F3 · derivative.exercise_date: The Employee Stock Option (right to buy) granted on November 10, 2016 had a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001689126-19-000001 · wf-form4_154816489841616.xml · derivative · entry 2

Clark Thomas Eugene · CIK 0001689126 · Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2026-02-01

F1 · kind: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") that became effective on January 17, 2019 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Employee Stock Option (right to buy) has been amended to reduce such exercise price by $2.30. There have been no other changes to the terms of the Employee Stock Option (right to buy). The Option Repricing was related to a special dividend declared in December 2018.

F2 · derivative.exercise_date: The Employee Stock Option (right to buy) granted on February 1, 2016 had a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001689126-19-000001 · wf-form4_154816489841616.xml · derivative · entry 1

Clark Thomas Eugene · CIK 0001689126 · Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2026-02-01

F1 · kind: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") that became effective on January 17, 2019 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Employee Stock Option (right to buy) has been amended to reduce such exercise price by $2.30. There have been no other changes to the terms of the Employee Stock Option (right to buy). The Option Repricing was related to a special dividend declared in December 2018.

F2 · derivative.exercise_date: The Employee Stock Option (right to buy) granted on February 1, 2016 had a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001243716-19-000002 · wf-form4_154816471289927.xml · derivative · entry 7

DOOLEY ROBERT · CIK 0001243716 · President, Industrial Prod GRP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,789

Underlying: Common Stock · 31,789 shares

Expires 2029-01-17

F5 · derivative.exercise_date: The Employee Stock Option (right to buy) granted on January 17, 2019 had a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001243716-19-000002 · wf-form4_154816471289927.xml · derivative · entry 6

DOOLEY ROBERT · CIK 0001243716 · President, Industrial Prod GRP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires 2026-12-14

F1 · kind: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") that became effective on January 17, 2019 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Employee Stock Option (right to buy) has been amended to reduce such exercise price by $2.30. There have been no other changes to the terms of the Employee Stock Option (right to buy). The Option Repricing was related to a special dividend declared in December 2018.

F4 · derivative.exercise_date: The Employee Stock Option (right to buy) granted on December 14, 2016 had a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001243716-19-000002 · wf-form4_154816471289927.xml · derivative · entry 5

DOOLEY ROBERT · CIK 0001243716 · President, Industrial Prod GRP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 37,500 shares

Expires 2026-12-14

F1 · kind: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") that became effective on January 17, 2019 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Employee Stock Option (right to buy) has been amended to reduce such exercise price by $2.30. There have been no other changes to the terms of the Employee Stock Option (right to buy). The Option Repricing was related to a special dividend declared in December 2018.

F4 · derivative.exercise_date: The Employee Stock Option (right to buy) granted on December 14, 2016 had a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001243716-19-000002 · wf-form4_154816471289927.xml · derivative · entry 4

DOOLEY ROBERT · CIK 0001243716 · President, Industrial Prod GRP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2026-02-01

F1 · kind: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") that became effective on January 17, 2019 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Employee Stock Option (right to buy) has been amended to reduce such exercise price by $2.30. There have been no other changes to the terms of the Employee Stock Option (right to buy). The Option Repricing was related to a special dividend declared in December 2018.

F3 · derivative.exercise_date: The Employee Stock Option (right to buy) granted on February 1, 2016 had a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001243716-19-000002 · wf-form4_154816471289927.xml · derivative · entry 3

DOOLEY ROBERT · CIK 0001243716 · President, Industrial Prod GRP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2026-02-01

F1 · kind: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") that became effective on January 17, 2019 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Employee Stock Option (right to buy) has been amended to reduce such exercise price by $2.30. There have been no other changes to the terms of the Employee Stock Option (right to buy). The Option Repricing was related to a special dividend declared in December 2018.

F3 · derivative.exercise_date: The Employee Stock Option (right to buy) granted on February 1, 2016 had a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001243716-19-000002 · wf-form4_154816471289927.xml · derivative · entry 2

DOOLEY ROBERT · CIK 0001243716 · President, Industrial Prod GRP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,348

Underlying: Common Stock · 20,348 shares

Expires 2022-03-01

F1 · kind: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") that became effective on January 17, 2019 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Employee Stock Option (right to buy) has been amended to reduce such exercise price by $2.30. There have been no other changes to the terms of the Employee Stock Option (right to buy). The Option Repricing was related to a special dividend declared in December 2018.

F2 · derivative.exercise_date: The Employee Stock Option (right to buy) granted on March 1, 2012 had a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001243716-19-000002 · wf-form4_154816471289927.xml · derivative · entry 1

DOOLEY ROBERT · CIK 0001243716 · President, Industrial Prod GRP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,348 shares

Expires 2022-03-01

F1 · kind: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") that became effective on January 17, 2019 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Employee Stock Option (right to buy) has been amended to reduce such exercise price by $2.30. There have been no other changes to the terms of the Employee Stock Option (right to buy). The Option Repricing was related to a special dividend declared in December 2018.

F2 · derivative.exercise_date: The Employee Stock Option (right to buy) granted on March 1, 2012 had a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001549062-19-000002 · wf-form4_154816405410453.xml · derivative · entry 5

Lerner Eric · CIK 0001549062 · Senior VP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,507

Underlying: Common Stock · 30,507 shares

Expires 2029-01-17

F4 · derivative.exercise_date: The Employee Stock Option (right to buy) granted on January 17, 2019 had a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001549062-19-000002 · wf-form4_154816405410453.xml · derivative · entry 4

Lerner Eric · CIK 0001549062 · Senior VP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2026-02-01

F1 · kind: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") that became effective on January 17, 2019 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Employee Stock Option (right to buy) has been amended to reduce such exercise price by $2.30. There have been no other changes to the terms of the Employee Stock Option (right to buy). The Option Repricing was related to a special dividend declared in December 2018.

F3 · derivative.exercise_date: The Employee Stock Option (right to buy) granted on February 1, 2016 had a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001549062-19-000002 · wf-form4_154816405410453.xml · derivative · entry 3

Lerner Eric · CIK 0001549062 · Senior VP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,500 shares

Expires 2026-02-01

F1 · kind: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") that became effective on January 17, 2019 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Employee Stock Option (right to buy) has been amended to reduce such exercise price by $2.30. There have been no other changes to the terms of the Employee Stock Option (right to buy). The Option Repricing was related to a special dividend declared in December 2018.

F3 · derivative.exercise_date: The Employee Stock Option (right to buy) granted on February 1, 2016 had a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001549062-19-000002 · wf-form4_154816405410453.xml · derivative · entry 2

Lerner Eric · CIK 0001549062 · Senior VP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,250

Underlying: Common Stock · 6,250 shares

Expires 2025-05-02

F1 · kind: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") that became effective on January 17, 2019 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Employee Stock Option (right to buy) has been amended to reduce such exercise price by $2.30. There have been no other changes to the terms of the Employee Stock Option (right to buy). The Option Repricing was related to a special dividend declared in December 2018.

F2 · derivative.exercise_date: The Employee Stock Option (right to buy) granted on May 2, 2015 had a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001549062-19-000002 · wf-form4_154816405410453.xml · derivative · entry 1

Lerner Eric · CIK 0001549062 · Senior VP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,250 shares

Expires 2025-05-02

F1 · kind: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") that became effective on January 17, 2019 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Employee Stock Option (right to buy) has been amended to reduce such exercise price by $2.30. There have been no other changes to the terms of the Employee Stock Option (right to buy). The Option Repricing was related to a special dividend declared in December 2018.

F2 · derivative.exercise_date: The Employee Stock Option (right to buy) granted on May 2, 2015 had a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001140170-19-000002 · wf-form4_154816387383654.xml · derivative · entry 3

AXMACHER THOMAS · CIK 0001140170 · VP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,255

Underlying: Common Stock · 9,255 shares

Expires 2029-01-17

F3 · derivative.exercise_date: The Employee Stock Option (right to buy) granted on January 17, 2019 had a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001140170-19-000002 · wf-form4_154816387383654.xml · derivative · entry 2

AXMACHER THOMAS · CIK 0001140170 · VP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2026-02-01

F1 · kind: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") that became effective on January 17, 2019 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Employee Stock Option (right to buy) has been amended to reduce such exercise price by $2.30. There have been no other changes to the terms of the Employee Stock Option (right to buy). The Option Repricing was related to a special dividend declared in December 2018.

F2 · derivative.exercise_date: The Employee Stock Option (right to buy) granted on February 1, 2016 had a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001140170-19-000002 · wf-form4_154816387383654.xml · derivative · entry 1

AXMACHER THOMAS · CIK 0001140170 · VP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2026-02-01

F1 · kind: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") that became effective on January 17, 2019 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Employee Stock Option (right to buy) has been amended to reduce such exercise price by $2.30. There have been no other changes to the terms of the Employee Stock Option (right to buy). The Option Repricing was related to a special dividend declared in December 2018.

F2 · derivative.exercise_date: The Employee Stock Option (right to buy) granted on February 1, 2016 had a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001615469-19-000002 · wf-form4_154816371812822.xml · derivative · entry 5

Shetty Manoj · CIK 0001615469 · Senior VP & Chief Info Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,250

Underlying: Common Stock · 24,250 shares

Expires 2029-01-17

F4 · derivative.exercise_date: The Employee Stock Option (right to buy) granted on January 17, 2019 have a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001615469-19-000002 · wf-form4_154816371812822.xml · derivative · entry 4

Shetty Manoj · CIK 0001615469 · Senior VP & Chief Info Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2026-01-01

F1 · kind: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") that became effective on January 17, 2019 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Employee Stock Option (right to buy) has been amended to reduce such exercise price by $2.30. There have been no other changes to the terms of the Employee Stock Option (right to buy). The Option Repricing was related to a special dividend declared in December 2018.

F3 · derivative.exercise_date: The Employee Stock Option (right to buy) granted on February 1, 2016 had a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.